Rua Marisa, 299 - Jardim Palma Travassos - Ribeirão Preto S.P.

16 - 3441.0787

logo

Ressicronizador Cardíaco

Abbott-SJM | Cardiovascular |
Untitled Document

DESCRIÇÃO

MORE OPTIONS TO MAKE NON-RESPONSE A NON-ISSUE

The Quadra Allure MP CRT-P brings MultiPoint™ Pacing, an exclusive Abbott technology, to cardiac resynchronization therapy pacemakers (CRT-Ps).

OVERVIEW MultiPoint Pacing technology is designed to deliver multiple independent left ventricular (LV) pacing pulses from a single quadripolar lead to provide you with CRT options to change:Pattern of depolarizationEngagement of areas around scar tissueHemodynamicsResynchronizationUsing the Quadra Allure MP™ CRT-P with Quartet™ quadripolar LV pacing lead, with its four pacing electrodes and 14 pacing vectors, provides more options and greater control in CRT response.

U.S. IDE STUDY: IMPORTANCE OF MPP™ TECHNOLOGY PROGRAMMING1 The recent IDE study1 post-hoc subanalysis (n = 199) showed that wider cathode spacing and near-simultaneous intraventricular timing delays provide best MPP technology response at 87 percent and "super-response" at 54 percent (52 patients).1See details of the U.S. IDE study and other clinical support for MultiPoint Pacing.

ADDITIONAL INTERNATIONAL CLINICAL DATA This evidence builds on our quadripolar standard of care, which has offered you more options to pace at the preferred LV site, resulting in:- Improved CRT outcome2,3- Fewer surgical revisions4 Reduced need for lead repositioning at implant, leading to shorter procedure times and decreased fluoroscopic exposure5,6- More basal pacing opportunities without compromising lead stability7,8

QUADRA ALLURE MP CRT-P ADVANCED FEATURES AND BENEFITS Designed to Optimize Tissue SelectionThe Quadra Allure MP CRT-P offers Auto VectSelect Quartet™ Test that:Automatically identifies tissue sites with the latest activation via RV-LV conduction delays measurementsPerforms threshold testing, assesses LVCap™ Confirm applicability and allows marking of PNSPacing at the tissue site of latest activation improves:Acute hemodynamic response9Reverse remodeling10Quality of life10

Enhanced Programming Options SyncAV™ CRT technology automatically adjusts pacing based on real-time changes in a patient's cardiac condition.

Providing Insightful Diagnostics and RF Monitoring Quadra Allure MP CRT-P helps you better manage your patients' heart failure with intuitive programming options and timely access to their vital heart failure diagnostic data through radio frequency (RF) monitoring, providing:CorVue™ congestion monitoring for an earlier insight into HF progressionDaily remote monitoring of AT/AF alerts for changes in the patient's AF conditionDirectTrend™ reports for a simplified look at all device data

BUILDING COMPREHENSIVE HEART FAILURE MANAGEMENT The Quadra Allure MP™ CRT-P Is one of our heart failure management therapies. Our vision is to transform the treatment of heart failure by designing technology that delivers excellent clinical outcomes and improves workflow and efficiency. Read more about our approach to heart failure management.

REFERENCES
1. Tomassoni, G., Baker II, J., Corbisiero, R., Love, C., Martin, D., Sheppard, R., Worley, S., Varma, N., & Niazi, I. (2016, May). Safety and efficacy of Multipoint Pacing in cardiac resynchronization therapy: The MultiPoint Pacing (MPP) IDE Study. Presented at the meeting of the Heart Rhythm Society, San Francisco, CA, LBCT 01-03.2. Forleo,. G. B., Mantica, M., Di Biase, L., Panattoni, G., Della Rocca, D. G., Papavasileiou, L. P., … Romeo, F. (2012). Clinical and procedural outcome of patients implanted with a quadripolar left ventricular lead: Early results of a prospective multicenter study. Heart Rhythm, 9(11), 1822-1828. http://dx.doi.org/10.1016/j.hrthm.2012.07.0123. Turakhia, M., Cao, M., Fischer, A., Arnold, E. M., Sloman, L. S., Dalal, N., & Gold, M. (2014, June). Reduced mortality with quadripolar compared to bipolar left ventricular leads in cardiac resynchronization therapy. Presented at the World Congress in Cardiac Electrophysiology and Cardiac Techniques, Nice, France. Retrospective analysis; not prespecified.4. Forleo, G. B., Della Rocca, D. G., Papavasileiou, L. P., Molfetta, A. D., Santini, L., & Romeo, F. (2011). Left ventricular pacing with a new quadripolar transvenous lead for CRT: Early results of a prospective comparison with conventional implant outcomes. Heart Rhythm, 8(1), 31-37. http://dx.doi.org/10.1016/j.hrthm.2010.09.0765. Dänschel, W., Sperzel, J. K., Gutleben, K., Kranig, W., Mortensen, P., Connelly, D., … Hallier, B. (2010). Initial clinical experience with a novel left ventricular quadripolar lead. Europace, 12(Suppl. 1), i127. http://dx.doi.org/10.1093/europace/euq1276. Duray, G. Z., Hohnloser, S. H., Israel, C. W. (2008). Coronary sinus side branches for cardiac resynchronization therapy: prospective evaluation of availability, implant success, and procedural determinants. Journal of Cardiovascular Electrophysiology, 19(5), 489-494. http://dx.doi.org/10.1111/j.1540-8167.2007.01096.x7. Merchant, F. M., Heist, E. K., McCarty, D., Kumar, P., Das, S., Blendea, D., … Singh, J. P. (2010). Impact of segmental left ventricular lead position on cardiac resynchronization therapy outcomes. Heart Rhythm, 7(5), 639-644. http://dx.doi.org/10.1016/j.htrhtm.2010.01.0358. Singh, J. P., Klein, H. U., Huang, D. T., Reek, S., Kuniss, M., Quesada, A., … Moss, A. J. (2011). Left ventricular lead position and clinical outcome in the Multicenter Automatic Defibrillator Implantation Trial Cardiac Resynchronization Therapy (MADIT-CRT) trial. Circulation, 123(11), 1159-1166. http://dx.doi.org/10.1161/CIRCULATIONAHA.110.0006469. Yu, Y., Auricchio, A., Butter, C., Stellbrink, C., Vogt, J., Goehring, A., & Spinelli, J. (2002). Assessment of resynchronization effectiveness of left ventricular lead site. Journal of Cardiac Failure, 8(4S), S72.10. Gold, M., Birgersdotter-Green, U., Singh J., Ellenbogen, K., Yu, Y., Meyer, T., …Tchou, P. (2011).The relationship between ventricular electrical delay and left ventricular remodeling with cardiac resynchronization therapy. European Heart Journal, 32(20), 2516-2524.http://dx.doi.org/10.1093/eurheartj/ehr329

 

 

Site Oficial: https://www.cardiovascular.abbott/us/en/hcp/products/heart-failure/quadra-allure-mp-rf-crt-p.html

Dúvida sobre o produto?